海角直播

North East launch for world leading RNA Training Academy

A new RNA training academy has been launched in Darlington help protect the world against future pandemics and infectious diseases.

The training academy has been launched by The National Horizons Centre, 海角直播's 拢22.3m centre of excellence for the global biosciences and healthcare sector, in conjunction with, CPI, a technology innovation organisation in the North East. RNA technology 鈥� the critical technology that has enabled the Pfizer and Moderna COVID-19 vaccines, has significant impact beyond COVID-19. RNA vaccines and medicines carry instructions that tell the body to produce a specific tool that can be used to fight infectious disease. It is very versatile and can be adapted to treat HIV, cancer, and even heart disease.

To prepare for global demand for this exciting emerging technology and to drive the crucial life science skills needed to support this emerging industry, a new National Training Academy for RNA Therapeutics and Vaccines Manufacture has been formed.

Led in partnership between National Horizons Centre and CPI, a series of courses to upskill technicians and scientists in the development and manufacture of RNA will be available from January 2022.

Dr Jen Vanderhoven, Director at the National Horizons Centre, said: 鈥淭ogether with our partners, we pride ourselves on discovering diseases earlier, developing novel treatments and delivering life-saving medicines quicker, safer and more affordably.

鈥淲ith specialisms in disease-specific research, biomanufacturing and digital analytics and machine learning, we work in an agile way to advance biosciences and healthcare research.

鈥淲e care about the future of the industry, which is why we train the workforce in cutting edge technologies, aligning closely with our partners to address the technical and digital skills needs of the sector.鈥�

The new courses will complement the already substantial training offering available at the National Horizons Centre in advanced therapies, vaccine manufacturing and bioprocessing.

Dr Vanderhoven added: 鈥淲ith research, partnerships, and training at our core, the NHC brings together industry, academia, talent and world-class facilities to create real-world impact.

鈥淭he global pandemic has shown the vital role that our sector plays, and it is important that we remain agile and responsive to ensure the UK remains a global life sciences leader.

鈥淲e are delighted to partner on this world leading collaboration, deepening our strategic partnership with CPI, to ensure the UK bioindustry has the future skilled workforce it needs.鈥�

Dr Lucy Foley, Director of Biologics at CPI, said: 鈥淭he agility of RNA technology makes it a real game changer for therapeutics. Having established itself as a breakthrough technology during the COVID-19 pandemic, we need to be prepared with the skills and facilities to support this emerging RNA industry.

鈥淏oth the RNA Centre of Excellence and Training Academy will support the development of new licensed RNA products for the treatment of many different diseases. This is fantastic news for the biopharmaceutical industry, and for human health.鈥�

Parliamentary Under Secretary of State (Minister for Business and Industry) and Parliamentary Under Secretary of State (Minister for COVID Vaccine Deployment), Nadhim Zahawi, said: 鈥淭his is another excellent example of the UK leading the way to harness some of the best scientific and medical minds in the world to develop life-saving treatments and vaccines.

鈥淎longside our fantastic COVID-19 vaccination programme - which has prevented more than 105,000 deaths and 24 million infections - medicines such as therapeutics are playing a fundamental role in helping return life to normal and keeping people safe.鈥�

---